Glembatumumab vedotin (GV), an anti-gpNMB antibody-drug conjugate (ADC), in combination with varlilumab (V), an anti-CD27 antibody, in advanced melanomaOmid Hamid,Anna C. Pavlick,C. Lance Cowey,Lowell Hart,Douglas B. Johnson,Jose Lutzky,Aaron Alizadeh,David Spigel, Neal Rothschild,April Salama,Robert Weber,Jason J. Luke,Ying Wang,Michael Yellin,Yi He,Rebecca G. Bagley,Patrick OttJOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
